Based on the current week's news, the sentiment is POSITIVE. The news states that Dr. Reddy's Laboratories shares have experienced a volume surge, resulting in a 1.18% increase. This suggests that the market is responding positively to the company's recent developments.

Notable events mentioned in the historical similar news include:

* A potential rebound in July 2021 after being India's worst-performing stock
* A court dismissal of claims against generic Revlimid in December 2022
* Seeking emergency use authorization for Sputnik V in India in February 2021

The tone of the news is overall positive, indicating that the company is experiencing a surge in volume and a subsequent increase in share price.